Index Capital
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 1
- Baiaogeometry Raises A+ Round as A-Series Funding Tops $100M
AI-native biopharmaceutical company Baiaogeometry announced an A+ financing round led by Guoshou Capital, with Shanghai Biopharmaceutical Fund increasing its investment and other firms participating. According to 36氪, the company’s cumulative A-series funding now exceeds US$100 million. The proceeds are earmarked for iterating the GeoFlow molecular-level and GeoCell cell-level world models, expanding high-throughput automated laboratories, and commercializing its proprietary drug pipeline.
36氪快讯 · 🔥 0
Experience and discussion from the community
Share my Index Capital experienceAsk about Index Capital
Nobody has shared their experience with Index Capital yet.